A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

In the long term (and depending on what the cardiac cath was for), you may have to make some lifestyle changes. For example, start eating a heart-healthy diet and exercising regularly. Everyday ...

UPMC Offers New Heart Treatment for Stent Patients UPMC Heart and Vascular Institute in Central Pa. has treated its first patient with a new therapy for in-stent restenosis (ISR), a condition in which ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...

For the first time, scientists are testing whether a first-of-its-kind drug inspired by spider venom can reverse the tissue damage caused by a heart attack ... For example, Hi1a could protect ...

The FDA has approved the Minima stent system, the first device specifically designed for infants and young children with congenital heart defects ... of the pediatric catheterization laboratory ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Intraosseous vascular access for the administration of ...

This targeted drug therapy is designed to mimic human antibodies and inhibit the activity of ENPP1, which Deb had previously established increases in the aftermath of a heart attack. The ...

Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or ...